For research use only. Not for therapeutic Use.
Mefatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1].
| Catalog Number | I041730 |
| CAS Number | 1989592-50-8 |
| Synonyms | (Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(difluoromethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide |
| Molecular Formula | C29H27ClF3N5O10 |
| Purity | ≥95% |
| InChI | InChI=1S/C21H19ClF3N5O2.2C4H4O4/c1-30(2)7-3-4-19(31)29-17-9-13-16(10-18(17)32-21(24)25)26-11-27-20(13)28-12-5-6-15(23)14(22)8-12;2*5-3(6)1-2-4(7)8/h3-6,8-11,21H,7H2,1-2H3,(H,29,31)(H,26,27,28);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1- |
| InChIKey | AUGQPHRSSXWEBH-LTOSPQESSA-N |
| SMILES | CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC(F)F.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O |
| Reference | [1]. WHO Drug Information-World Health Organization (WHO). |
